Vigiis® 101-LAB
Market Insights

We’re proud to announce that our flagship probiotic strain — Lactobacillus paracasei NTU 101, marketed as #Vigiis101 — has officially received GRAS (Generally Recognized As Safe) status, GRN 001232, from the U.S. Food and Drug Administration (FDA). This is the first-ever GRAS recognition for L. paracasei from Taiwan, highlighting SunWay Biotech’s excellence in R&D and our strategic vision for the global probiotic market.
The first clinical study, which has been published in Heliyon, documents that Vigiis® 101-LAB significantly increases the bacterial counts of Bifidobacterium spp. and Lactobacillus spp. in feces in just one week, and maintains those elevated counts for four weeks.
Contact Us